Press Release Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights 1 hour ago
Press Release Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) 2 hours ago